Research Topics
| RICHARD GABRIEL FRANKSummaryAffiliation: Harvard University Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Mental health policy and psychotropic drugsRichard G Frank
Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA 02115, USA
Milbank Q 83:271-98. 2005..This article outlines the policy issues related to psychotropic drugs with respect to their role in determining access to mental health treatment and the cost and quality of mental health care...
The creation of Medicare and Medicaid: the emergence of insurance and markets for mental health servicesR G Frank
Harvard University, 180 Longwood Avenue, Boston, MA 02115 5899, USA
Psychiatr Serv 51:465-8. 2000..He shows that many of the themes raised at the 1965 APA conference on Medicare legislation for psychiatric disorders continue to dominate public debate...- Managed behavioral health care carve-outs: past performance and future prospectsRichard G Frank
Department of Health Care Policy, Harvard University, Boston, MA 02115, USA
Annu Rev Public Health 28:303-20. 2007..Although not perfect, carve-outs have been instrumental in addressing long-standing challenges in utilization, access, and cost of behavioral health care... - Mental health in the mainstream of health careRichard G Frank
Harvard University, Boston, Massachusetts, USA
Health Aff (Millwood) 26:1539-41. 2007..Continued progress in the well-being of people with mental disorders requires expanded engagement of the mental health community with mainstream health policymakers... - Custom-made versus ready-to-wear treatments: behavioral propensities in physicians' choicesRichard G Frank
Harvard University Boston, MA, USA
J Health Econ 26:1101-27. 2007..Some such behavior, from our studies and from the literature, proves sensible; but other behavior seems far from optimal... 
Should drug prices be negotiated under part D of Medicare? And if so, how?Richard G Frank
Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA
Health Aff (Millwood) 27:33-43. 2008..We make a modest proposal for how to improve purchasing of prescription drugs in Medicare...- Policy toward second-generation antipsychotic drugs: a cautionary noteRichard G Frank
Department of Health Care Policy, Harvard University, Boston, MA 02115, USA
Psychiatr Serv 59:521-2. 2008 - Talbott and financing policy: Reducing fragmentationRichard G Frank
Department of Health Care Policy, Harvard University Medical School, 180 Longwood Avenue, Boston, Massachusetts 02115, USA
Psychiatr Serv 55:1150-1. 2004 - Trends in mental health cost growth: an expanded role for management?Richard G Frank
Department of Health Care Policy at Harvard Medical School in Boston, Massachusetts, USA
Health Aff (Millwood) 28:649-59. 2009..We show that in spite of this convergence, important differences remain between general health and mental health care in patterns of spending growth... - Measuring adverse selection in managed health careR G Frank
Harvard University, Harvard Medical School, Department of Health Care Policy, Boston, MA 02115, USA
J Health Econ 19:829-54. 2000..These factors are combined in an empirically implementable index that can be used to identify the services that will be most distorted by selection incentives... - Government commitment and regulation of prescription drugsRichard G Frank
Department of Health Care Policy, Harvard Medical School, Boston, USA
Health Aff (Millwood) 22:46-8. 2003..I conclude that the federal government should exercise caution when attempting to regulate prescription drug prices... - Medicaid and mental health: be careful what you ask forRichard G Frank
Department of Health Care Policy, Harvard Medical School, Boston, USA
Health Aff (Millwood) 22:101-13. 2003..The result has been a tilting of public mental health care toward Medicaid-covered people and services... - Design of mental health benefits: still unequal after all these yearsColleen L Barry
Department of Health Policy, Harvard Medical School, Boston, USA
Health Aff (Millwood) 22:127-37. 2003..We attempt to synthesize these data with prior research as a foundation for informed debates... - Depression in primary care: quality improvement and economicsRichard G Frank
Department of Health Care Policy, Harvard Medical School, USA
Manag Care 17:22-4; discussion 25-6. 2008 - Impact of alternative interventions on changes in generic dispensing ratesRichard G Frank
Department of Health Care Policy, 180 Longwood Avenue, Boston, MA 02115-5899, USA
Health Serv Res 41:1876-94. 2006..Financial incentives expressed to consumers through benefit designs have a large influence on their switching to generic drugs and on the less-costly mail-order mode of purchase... - Changes in mental health financing since 1971: implications for policymakers and patientsRichard G Frank
Department of Health Care Policy, Harvard University, Cambridge, Massachusetts, USA
Health Aff (Millwood) 25:601-13. 2006..Recent developments suggest that financing could be further constrained in the future, even as fragmentation continues to increase... - The ongoing regulation of generic drugsRichard G Frank
Harvard Medical School, Boston, USA
N Engl J Med 357:1993-6. 2007 - Prescription-drug pricesRichard G Frank
Department of Health Care Policy, Harvard Medical School, Boston, USA
N Engl J Med 351:1375-7. 2004 - Pay for performance in commercial HMOsMeredith B Rosenthal
Department of Health Policy and Management, Harvard School of Public Health, Boston, USA
N Engl J Med 355:1895-902. 2006..As the design of Medicare with pay for performance moves forward, it will be important to leverage the early experience of pay for performance in the commercial market... - The medical treatment of depression, 1991-1996: productive inefficiency, expected outcome variations, and price indexesErnst R Berndt
MIT and NBER, Boston, MA 02127, USA
J Health Econ 21:373-96. 2002..Based on hedonic regression equations that account for the effects of changing patient mix, we find reductions that range from about -1.66 to -2.13% per year... - Part D and dually eligible patients with mental illness: medication access problems and use of intensive servicesHaiden A Huskamp
Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
Psychiatr Serv 60:1169-74. 2009.... - Was Part D a giveaway to the pharmaceutical industry?Joseph P Newhouse
Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
Inquiry 44:15-25. 2007..However, if the prior rate of introduction resumes, the government may find itself with unacceptable expenditure levels... - Behavioral health services for women who have breast cancerVanessa Azzone
Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
J Clin Oncol 27:706-12. 2009.... - The impact of mental health on labour market outcomes in ChinaChunling Lu
Department of Global Health and Social Medicine, Harvard Medical School, 800 Boylston Street 47 th Floor, Boston, MA 02199, USA
J Ment Health Policy Econ 12:157-66. 2009..Mental illnesses account for 20% of the total burden of disease in China. Yet, health policy in China has not devoted much attention to mental health problems and their impact on Chinese society... - Changes over time and disparities in schizophrenia treatment qualityAlisa B Busch
Department of Psychiatry, McLean Hospital, Alcohol and Drug Abuse Treatment Program, Belmont, Massachusetts, USA
Med Care 47:199-207. 2009..However, there also have been considerable changes in the delivery of mental health care in the public sector, as well as increasing state concerns about Medicaid cost containment... - Demand response of mental health services to cost sharing under managed careChunling Lu
Harvard Global Health Initiative, 104 Mt Auburn Street, Cambridge, MA 02138, USA
J Ment Health Policy Econ 11:113-25. 2008..The economics of parity under managed care needs to be under re-examination... - Effect of insurance parity on substance abuse treatmentVanessa Azzone
Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
Psychiatr Serv 62:129-34. 2011..This study examined the impact of insurance parity on the use, cost, and quality of substance abuse treatment... - Private long-term care insurance and state tax incentivesDavid G Stevenson
Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02115, USA
Inquiry 46:305-21. 2009..Ultimately, the modest ability of state tax incentives to lower premiums implies that they should be viewed as a small piece of the long-term care financing puzzle... - Employers' use of value-based purchasing strategiesMeredith B Rosenthal
Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts 02115, USA
JAMA 298:2281-8. 2007.... - Generic entry, reformulations and promotion of SSRIs in the USHaiden A Huskamp
Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
Pharmacoeconomics 26:603-16. 2008..However, little is known about how newer strategies to extend patent life, including product reformulation introduction or obtaining approval to market for additional clinical indications, influence promotion... - The rise and fall of gabapentin for bipolar disorder: a case study on off-label pharmaceutical diffusionCatherine A Fullerton
Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA 02478, USA
Med Care 48:372-9. 2010..The case of gabapentin use in bipolar disorder provides an opportunity to study the roles of marketing, clinical evidence, and prior authorization (PA) policy on off-label medication use... - Quality monitoring and management in commercial health plansBruce E Landon
Department of Health Care Policy, Harvard Medical School, 180 Longwood Ave, Boston, MA 02459, USA
Am J Manag Care 14:377-86. 2008..To examine the current state of quality monitoring and management activities of US health plans... - Spending on substance abuse treatment: how much is enough?Ellen Meara
Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
Addiction 100:1240-8. 2005..To describe a framework that can be used to determine optimal spending on substance abuse treatment in the United States... - Changes in the quality of care for bipolar I disorder during the 1990sAlisa B Busch
Alcohol and Drug Abuse Treatment Program, McLean Hospital, Proctor Building, 115 Mill St, Belmont, MA 02478, USA
Psychiatr Serv 58:27-33. 2007..This study estimated changes during the 1990s in the quality of usual-care treatment among persons diagnosed as having bipolar I disorder in a privately insured population... - Treatment for substance use disorders in a privately insured population under managed care: costs and services useShelly F Greenfield
McLean Hospital, 115 Mill Street, Belmont, MA 02478, USA
J Subst Abuse Treat 27:265-75. 2004..A significant minority also sought MHSA services in the medical sector. Understanding services use and associated costs can best be achieved by examining services use across treatment sectors... - Savings from drug discount cards: relief for Medicare beneficiaries?Juliette Cubanski
Program in Health Policy, Harvard University, Boston, Massachusetts, USA
Health Aff (Millwood) . 2004..Aggregate savings estimates vary widely, based on uncertainty in discounts and program participation rates... - The effect of a managed behavioral health carve-out on quality of care for medicaid patients diagnosed as having schizophreniaAlisa B Busch
Department of Psychiatry, Harvard Medical School, Boston, MA, USA
Arch Gen Psychiatry 61:442-8. 2004..The evidence on quality impacts is limited and suggests comparable quality overall, except that people with severe psychiatric disorders may be those most disadvantaged by MBHCOs... - The effect of incentive-based formularies on prescription-drug utilization and spendingHaiden A Huskamp
Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
N Engl J Med 349:2224-32. 2003..Many employers and health plans have adopted incentive-based formularies in an attempt to control prescription-drug costs... - "Usual care" for major depression in the 1990s: characteristics and expert-estimated outcomesMarcela Horvitz-Lennon
Department of Psychiatry, The Cambridge Hospital, Mass, USA
Am J Psychiatry 160:720-6. 2003.... - Evaluating selection out of health plans for Medicaid beneficiaries with substance abuseSharon Lise T Normand
Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA 02115, USA
J Behav Health Serv Res 30:78-92. 2003..These results suggest that current risk-adjustment systems may fail to offset selection incentives in modern capitated health plans... - Using elicitation techniques to estimate the value of ambulatory treatments for major depressionSharon Lise T Normand
Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts 02115, USA
Med Decis Making 22:245-61. 2002..The average spending for all observed treatments was $473 (SE = 478), with a depression-free adjusted price per case of $5,995 (95% confidence interval = $5,959-$6,031)... - Economic grand rounds: economics and the Surgeon General's Report on Mental HealthColleen L Barry
Harvard Medical School, Boston, Massachusetts 02115, USA
Psychiatr Serv 53:409-11. 2002 - Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in childrenHaiden A Huskamp
Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA 02115, USA
Arch Gen Psychiatry 62:435-41. 2005..Many employers and health plans have adopted 3-tier formularies in an attempt to control costs for these and other drugs... - Prevalence and treatment of mental disorders, 1990 to 2003Ronald C Kessler
Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
N Engl J Med 352:2515-23. 2005..Although the 1990s saw enormous change in the mental health care system in the United States, little is known about changes in the prevalence or rate of treatment of mental disorders... - Impact of a media campaign for disaster mental health counseling in post-September 11 New YorkRichard G Frank
Department of Health Care Policy, Harvard Medical School, Boston, USA
Psychiatr Serv 57:1304-8. 2006..CONCLUSIONS: Sustained advertising through multiple media outlets appeared to be effective in encouraging individuals to seek mental health services... - Schizophrenia, co-occurring substance use disorders and quality of care: the differential effect of a managed behavioral health care carve-outAlisa B Busch
Alcohol and Drug Abuse Treatment Program and the Department of Health Care Policy, McLean Hospital and Harvard Medical School, Proctor Building, 115 Mill St, Belmont, MA 02446, USA
Adm Policy Ment Health 33:388-97. 2006..Most pronounced across both populations were decrements in receiving the psychosocial treatments for enrollees in the CO arrangement... - Promotion of prescription drugs to consumersMeredith B Rosenthal
Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115, USA
N Engl J Med 346:498-505. 2002..Guidelines issued in 1997 by the Food and Drug Administration (FDA) regarding advertising to consumers through electronic media are considered by some to be responsible for unleashing a flood of direct-to-consumer advertising... - The impact of parity on major depression treatment quality in the Federal Employees' Health Benefits Program after parity implementationAlisa B Busch
Department of Psychiatry, Harvard Medical School, McLean Hospital, Alcohol and Drug Abuse Treatment Program, Belmont, Massachusetts 02478, USA
Med Care 44:506-12. 2006..Major depressive disorder (MDD) is a prevalent but often undetected and undertreated and thus could potentially benefit from parity implementation... - A meta-analysis of labor supply effects of interventions for major depressive disorderJustin W Timbie
Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Suite 301, Boston, Massachusetts 02115, USA
Psychiatr Serv 57:212-8. 2006..The aims of this study were to examine labor supply effects of interventions for major depressive disorder and to compare these effects with a summary measure of clinical effectiveness... - Early experience with pay-for-performance: from concept to practiceMeredith B Rosenthal
Department of Health Policy and Management, Harvard School of Public Health, Boston, Mass 02115, USA
JAMA 294:1788-93. 2005..Although there is intense interest in and optimism about pay-for-performance programs, there is little published research on pay-for-performance in health care... - Aligning incentives in the treatment of depression in primary care with evidence-based practiceRichard G Frank
Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA 02115, USA
Psychiatr Serv 54:682-7. 2003.... - What is the empirical basis for paying for quality in health care?Meredith B Rosenthal
Harvard University, USA
Med Care Res Rev 63:135-57. 2006..Even in non-health settings, however, where the institutional features are more favorable to a positive impact, the literature contains mixed results on the effectiveness of analogous pay-for-performance schemes... - Regulation of follow-on biologicsRichard G Frank
Harvard Medical School, Boston, USA
N Engl J Med 357:841-3. 2007 - Estimating Medicare Part D's impact on medication access among dually eligible beneficiaries with mental disordersJulie Marie Donohue
Graduate School of Public Health, University of Pittsburgh, 130 De Soto St, A613, Crabtree Hall, Pittsburgh, PA 15261, USA
Psychiatr Serv 58:1285-91. 2007..The objective of this study was to estimate rates of medication switching among dually eligible beneficiaries using antidepressants, antipsychotics, and mood stabilizers attributable to their enrollment in Medicare drug plans...
Research Grants
- PRICE INDEXES OF MENTAL HEALTH TREATMENTRichard Frank; Fiscal Year: 2002..To assess outcomes we will use clinical literature along with three expert panels of clinician-researchers to rate expected outcomes for specific combinations of consumers and treatments. ..
- Economic Impacts of New DrugsSharon Lise Normand; Fiscal Year: 2006..Finally, we will examine the proposition that offsets occur differentially across racial and ethnic groups, for high utilizers and according to the organization of insurance arrangements. ..
- HEALTH POLICY TRAINING PROGRAMRichard Frank; Fiscal Year: 2007..The program is located in a growing research community of mental health policy researchers that is highly energetic, productive, collaborative and supportive of scholars that are early in their careers. ..